Merge Extends Hyland Partnership - Analyst Blog
March 05 2013 - 9:40AM
Zacks
Imaging and interoperability
solutions provider Merge Healthcare Incorporated
(MRGE) and Hyland Software Inc., a developer of enterprise content
management (ECM), extended their long-established partnership to
include an integrated comprehensive system for image viewing and
storage.
The integrated solution supplements Hyland’s software suite –
OnBase for Health Information Management workflows, electronic
medical record (EMR) integration and Release of Information
capabilities. OnBase involves a wide range of clinical and
administrative workflow capabilities. The integrated solution by
Hyland and Merge Healthcare will provide access to diagnostic data,
both DICOM and non-DICOM, from any EMR on the back of iConnect
Access platform and OnBase.
Merge Healthcare’s vendor neutral archive (VNA), dubbed iConnect
Enterprise Archive, will enable reciprocal operations in the client
organizations by avoiding imaging silos. This in turn will minimize
storage costs over the long haul and facilitate connectivity to
dissimilar systems.
The collective solution by Merge Healthcare and Hyland will support
the enterprise efforts to meet the Stage 2 criteria of the
Meaningful Use incentive program via image enablement of the EMR.
The combined solution will also enable client organizations to
reach HIMSS Stage 7 status of EMR adoption.
According to Merge Healthcare, its iConnect Enterprise Archive is a
VNA pioneer, overseeing and storing 37% of the global images. The
extended partnership with Hyland is expected to improve workflow
efficacy and image management for its customers.
Innovation has been an aggressive strategy for Merge Healthcare to
drive growth. Its undertaking to expand its portfolio to meet the
growing needs of a multi-billion dollar market is encouraging. The
company is also well placed to benefit from the strong demand for
EMR-related software in the foreseeable future on the back of the
Stimulus bill. As healthcare providers adopt EMR, the demand for
Merge Healthcare’s solutions is expected to increase.
We believe that innovation and contract wins for Merge Healthcare
will support growth amid a challenging reimbursement environment
and sluggish hospital spending in the U.S. With a consentient
upward revision in earnings estimate, the stock carries a Zacks
Rank #2 (Buy). Other Zacks Rank #2 medical stocks are
Edwards Lifesciences (EW), Myriad
Genetics (MYGN) and Conceptus (CPTS).
CONCEPTUS INC (CPTS): Free Stock Analysis Report
EDWARDS LIFESCI (EW): Free Stock Analysis Report
MERGE HEALTHCAR (MRGE): Free Stock Analysis Report
MYRIAD GENETICS (MYGN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mirage Energy (PK) (USOTC:MRGE)
Historical Stock Chart
From Jul 2023 to Jul 2024